These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The Role of Surgery in Metastatic Gastrointestinal Stromal Tumors. Keung EZ; Fairweather M; Raut CP Curr Treat Options Oncol; 2016 Feb; 17(2):8. PubMed ID: 26820287 [TBL] [Abstract][Full Text] [Related]
3. Cytoreductive Surgery for Metastatic Gastrointestinal Stromal Tumors Treated With Tyrosine Kinase Inhibitors: A 2-institutional Analysis. Fairweather M; Balachandran VP; Li GZ; Bertagnolli MM; Antonescu C; Tap W; Singer S; DeMatteo RP; Raut CP Ann Surg; 2018 Aug; 268(2):296-302. PubMed ID: 28448384 [TBL] [Abstract][Full Text] [Related]
4. Ripretinib for the treatment of advanced gastrointestinal stromal tumor. Zalcberg JR Therap Adv Gastroenterol; 2021; 14():17562848211008177. PubMed ID: 33948116 [TBL] [Abstract][Full Text] [Related]
5. The INSIGHT study: a randomized, Phase III study of ripretinib versus sunitinib for advanced gastrointestinal stromal tumor with George S; Blay JY; Chi P; Jones RL; Serrano C; Somaiah N; Gelderblom H; Zalcberg JR; Reichmann W; Sprott K; Cox P; Sherman ML; Ruiz-Soto R; Heinrich MC; Bauer S Future Oncol; 2024; 20(27):1973-1982. PubMed ID: 39229786 [TBL] [Abstract][Full Text] [Related]
6. Systemic Therapy for Gastrointestinal Stromal Tumor: Current Standards and Emerging Challenges. Huang WK; Wu CE; Wang SY; Chang CF; Chou WC; Chen JS; Yeh CN Curr Treat Options Oncol; 2022 Sep; 23(9):1303-1319. PubMed ID: 35976553 [TBL] [Abstract][Full Text] [Related]
7. Tyrosine kinase inhibitors in the treatment of unresectable or metastatic gastrointestinal stromal tumors. Nishida T; Doi T; Naito Y Expert Opin Pharmacother; 2014 Oct; 15(14):1979-89. PubMed ID: 24990162 [TBL] [Abstract][Full Text] [Related]
8. Surgery for metastatic gastrointestinal stromal tumor: to whom and how to? Kikuchi H; Hiramatsu Y; Kamiya K; Morita Y; Sakaguchi T; Konno H; Takeuchi H Transl Gastroenterol Hepatol; 2018; 3():14. PubMed ID: 29682621 [TBL] [Abstract][Full Text] [Related]
9. Emerging drugs for the treatment of gastrointestinal stromal tumors. Pilco-Janeta DF; García-Valverde A; Gomez-Peregrina D; Serrano C Expert Opin Emerg Drugs; 2021 Mar; 26(1):53-62. PubMed ID: 33645383 [TBL] [Abstract][Full Text] [Related]
10. Systemic therapy of advanced/metastatic gastrointestinal stromal tumors: an update on progress beyond imatinib, sunitinib, and regorafenib. Mohammadi M; Gelderblom H Expert Opin Investig Drugs; 2021 Feb; 30(2):143-152. PubMed ID: 33252274 [No Abstract] [Full Text] [Related]
11. The multifaceted landscape behind imatinib resistance in gastrointestinal stromal tumors (GISTs): A lesson from ripretinib. Di Vito A; Ravegnini G; Gorini F; Aasen T; Serrano C; Benuzzi E; Coschina E; Monesmith S; Morroni F; Angelini S; Hrelia P Pharmacol Ther; 2023 Aug; 248():108475. PubMed ID: 37302758 [TBL] [Abstract][Full Text] [Related]
12. Prediction of morbidity following cytoreductive surgery for metastatic gastrointestinal stromal tumour in patients on tyrosine kinase inhibitor therapy. Fairweather M; Cavnar MJ; Li GZ; Bertagnolli MM; DeMatteo RP; Raut CP Br J Surg; 2018 May; 105(6):743-750. PubMed ID: 29579329 [TBL] [Abstract][Full Text] [Related]
13. [Gastrointestinal stromal tumors (GIST)]. Jaros D; Bozic B; Sebesta C Wien Med Wochenschr; 2023 Jun; 173(9-10):201-205. PubMed ID: 36155864 [TBL] [Abstract][Full Text] [Related]
14. Current status of and future prospects for the treatment of unresectable or metastatic gastrointestinal stromal tumours. Naito Y; Nishida T; Doi T Gastric Cancer; 2023 May; 26(3):339-351. PubMed ID: 36913072 [TBL] [Abstract][Full Text] [Related]
15. Surgical management of patients with progressing metastatic gastrointestinal stromal tumors receiving sunitinib treatment: A prospective cohort study. Yeh CN; Wang SY; Tsai CY; Chen YY; Liu CT; Chiang KC; Chen TW; Liu YY; Yeh TS Int J Surg; 2017 Mar; 39():30-36. PubMed ID: 28110026 [TBL] [Abstract][Full Text] [Related]
16. The management of metastatic GIST: current standard and investigational therapeutics. Kelly CM; Gutierrez Sainz L; Chi P J Hematol Oncol; 2021 Jan; 14(1):2. PubMed ID: 33402214 [TBL] [Abstract][Full Text] [Related]
17. Long-term survival outcome with tyrosine kinase inhibitors and surgical intervention in patients with metastatic or recurrent gastrointestinal stromal tumors: A 14-year, single-center experience. Kim JH; Ryu MH; Yoo C; Chae H; Na H; Beck M; Kim BS; Yoo MW; Yook JH; Kim BS; Kim KH; Kim CW; Kang YK Cancer Med; 2019 Mar; 8(3):1034-1043. PubMed ID: 30693663 [TBL] [Abstract][Full Text] [Related]
18. Managing progressive disease in patients with GIST: factors to consider besides acquired secondary tyrosine kinase inhibitor resistance. Patel S Cancer Treat Rev; 2012 Aug; 38(5):467-72. PubMed ID: 22035971 [TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal Stromal Tumors: What Is the Best Sequence of TKIs? Senchak J; Ahr K; von Mehren M Curr Treat Options Oncol; 2022 May; 23(5):749-761. PubMed ID: 35349049 [TBL] [Abstract][Full Text] [Related]
20. Surgical intervention for imatinib and sunitinib-resistant gastrointestinal stromal tumors. Kikuchi H; Setoguchi T; Miyazaki S; Yamamoto M; Ohta M; Kamiya K; Sakaguchi T; Konno H Int J Clin Oncol; 2011 Dec; 16(6):741-5. PubMed ID: 21394667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]